Centers for Biologics Evaluation and Research (CBER)

The Centers for Biologics Evaluation and Research (CBER) is a division of the U.S. Food and Drug Administration (FDA) responsible for regulating biological products, such as vaccines, blood products, gene therapies, and cellular treatments. CBER ensures these products are safe, effective, and of high quality before they reach the public. The agency reviews scientific data, monitors products after approval, and works to protect public health by overseeing the development, manufacturing, and safety of biological medicines.